Intraductal carcinoma of the prostate (IDC-P) is a very aggressive histopathological subtype of prostate cancer (PCa) that is strongly associated with poor clinical outcomes but for which no accurate biomarkers exist. Here, we demonstrate a novel app...
Medical science monitor : international medical journal of experimental and clinical research
Oct 19, 2025
BACKGROUND Accurate spatial correlation between preoperative prostate MRI and post-prostatectomy histopathology is critical for improving prostate cancer diagnosis, treatment planning, and MRI interpretation. Current manual registration methods are t...
The seminal vesicle region plays a crucial role in male reproductive health, and its accurate evaluation is essential for diagnosing infertility and carcinoma. Magnetic resonance imaging (MRI) is the primary modality for assessment; however, manual e...
The aggressiveness of prostate cancer is primarily assessed from histopathological data using the Gleason scoring system. Conventional artificial intelligence (AI) approaches can predict Gleason scores, but often lack explainability, which may limit ...
Proposed methods for prostate cancer screening are currently prohibitively expensive (due to the high costs of imaging equipment such as magnetic resonance imaging and traditional ultrasound systems), inadequate in their detection rates, require high...
Prostate cancer is a major global health challenge. In this study, we present an approach for the detection and grading of prostate cancer through the semantic segmentation of adenocarcinoma tissues, specifically focusing on distinguishing between Gl...
The ProVision scanner is a dedicated prostate positron emission tomography (PET) system with limited angular coverage; it employs a new detector technology that provides high spatial resolution as well as information about depth-of-interaction (DOI) ...
BACKGROUND: To develop and validate a deep learning pipeline using prostate biopsy H&E slides to predict extraprostatic extension (EPE) in prostate cancer (PCa) patients.
Diagnostic needle biopsies that miss clinically significant prostate cancer (PCa) often sample benign tissue near hidden cancers. Such benign samples might still display subtle morphological signs of cancer elsewhere in the prostate. This study exami...
INTRODUCTION: Histopathological evaluation of prostate biopsies using the Gleason scoring system is critical for prostate cancer diagnosis and treatment selection. However, grading variability among pathologists can lead to inconsistent assessments, ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.